Concepts (291)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Laser Therapy | 24 | 2020 | 411 | 4.200 |
Why?
|
| Magnetic Resonance Imaging | 58 | 2021 | 7702 | 3.170 |
Why?
|
| Surgery, Computer-Assisted | 8 | 2021 | 255 | 1.760 |
Why?
|
| Nanoshells | 7 | 2013 | 43 | 1.640 |
Why?
|
| Hyperthermia, Induced | 16 | 2020 | 510 | 1.470 |
Why?
|
| Thermography | 5 | 2014 | 59 | 1.320 |
Why?
|
| Gold | 15 | 2015 | 270 | 1.310 |
Why?
|
| Ultrasonic Therapy | 7 | 2013 | 55 | 1.300 |
Why?
|
| Temperature | 16 | 2014 | 506 | 1.260 |
Why?
|
| Physics | 2 | 2020 | 44 | 1.210 |
Why?
|
| Body Temperature | 6 | 2014 | 158 | 1.200 |
Why?
|
| Therapy, Computer-Assisted | 7 | 2011 | 61 | 1.170 |
Why?
|
| Dogs | 23 | 2013 | 1155 | 1.040 |
Why?
|
| Hot Temperature | 11 | 2011 | 281 | 1.000 |
Why?
|
| Image Interpretation, Computer-Assisted | 4 | 2014 | 592 | 0.970 |
Why?
|
| Magnetic Resonance Imaging, Interventional | 6 | 2021 | 96 | 0.920 |
Why?
|
| Algorithms | 14 | 2014 | 3890 | 0.800 |
Why?
|
| Brain | 10 | 2014 | 4113 | 0.780 |
Why?
|
| Prostatic Neoplasms | 12 | 2016 | 5767 | 0.690 |
Why?
|
| Radiotherapy, Image-Guided | 2 | 2016 | 304 | 0.610 |
Why?
|
| Echo-Planar Imaging | 5 | 2011 | 73 | 0.540 |
Why?
|
| Phantoms, Imaging | 16 | 2013 | 1271 | 0.530 |
Why?
|
| Nanospheres | 3 | 2011 | 35 | 0.530 |
Why?
|
| Ablation Techniques | 2 | 2014 | 148 | 0.510 |
Why?
|
| Patient Safety | 1 | 2020 | 649 | 0.500 |
Why?
|
| Nanotubes | 1 | 2013 | 28 | 0.470 |
Why?
|
| Nanoparticles | 5 | 2012 | 554 | 0.470 |
Why?
|
| Image Enhancement | 5 | 2014 | 561 | 0.470 |
Why?
|
| Lasers | 8 | 2020 | 198 | 0.460 |
Why?
|
| Venereal Tumors, Veterinary | 2 | 2012 | 8 | 0.460 |
Why?
|
| Models, Biological | 6 | 2011 | 3254 | 0.460 |
Why?
|
| Computer Simulation | 9 | 2011 | 1529 | 0.430 |
Why?
|
| Disease Models, Animal | 9 | 2013 | 7222 | 0.420 |
Why?
|
| Thermodynamics | 2 | 2010 | 196 | 0.420 |
Why?
|
| Models, Theoretical | 2 | 2013 | 785 | 0.400 |
Why?
|
| Medicine | 1 | 2013 | 137 | 0.390 |
Why?
|
| Osteotomy | 1 | 2011 | 100 | 0.370 |
Why?
|
| Animals | 48 | 2015 | 59536 | 0.370 |
Why?
|
| Femur | 1 | 2011 | 158 | 0.370 |
Why?
|
| Neoplasms, Experimental | 3 | 2010 | 750 | 0.370 |
Why?
|
| Low-Level Light Therapy | 1 | 2010 | 24 | 0.360 |
Why?
|
| Brachytherapy | 4 | 2016 | 977 | 0.360 |
Why?
|
| Muscle Neoplasms | 2 | 2011 | 109 | 0.360 |
Why?
|
| Elasticity Imaging Techniques | 3 | 2019 | 171 | 0.360 |
Why?
|
| Biomedical Engineering | 1 | 2009 | 45 | 0.340 |
Why?
|
| Ultrasonography, Mammary | 1 | 2011 | 380 | 0.330 |
Why?
|
| Mastectomy, Segmental | 1 | 2014 | 1026 | 0.320 |
Why?
|
| Optics and Photonics | 1 | 2009 | 146 | 0.310 |
Why?
|
| Bone Neoplasms | 5 | 2011 | 2576 | 0.310 |
Why?
|
| Image Processing, Computer-Assisted | 9 | 2013 | 1648 | 0.290 |
Why?
|
| Water | 4 | 2013 | 361 | 0.280 |
Why?
|
| Computer Systems | 4 | 2013 | 106 | 0.280 |
Why?
|
| Inflammatory Breast Neoplasms | 1 | 2011 | 509 | 0.280 |
Why?
|
| Drug Delivery Systems | 4 | 2013 | 669 | 0.280 |
Why?
|
| Prostate | 3 | 2007 | 1088 | 0.270 |
Why?
|
| Models, Statistical | 7 | 2011 | 1171 | 0.270 |
Why?
|
| Finite Element Analysis | 3 | 2013 | 57 | 0.250 |
Why?
|
| Brain Neoplasms | 8 | 2020 | 4849 | 0.230 |
Why?
|
| Contrast Media | 9 | 2014 | 1472 | 0.230 |
Why?
|
| Bone Marrow | 1 | 2011 | 2358 | 0.230 |
Why?
|
| Feasibility Studies | 10 | 2012 | 2292 | 0.220 |
Why?
|
| Humans | 48 | 2020 | 261506 | 0.210 |
Why?
|
| Silicon Dioxide | 2 | 2013 | 50 | 0.210 |
Why?
|
| High-Intensity Focused Ultrasound Ablation | 1 | 2021 | 7 | 0.200 |
Why?
|
| Soft Tissue Injuries | 2 | 1999 | 51 | 0.200 |
Why?
|
| Reproducibility of Results | 8 | 2014 | 6009 | 0.200 |
Why?
|
| Ultrasonics | 3 | 2010 | 69 | 0.190 |
Why?
|
| Kidney | 2 | 2000 | 2146 | 0.190 |
Why?
|
| Laser Coagulation | 3 | 2006 | 136 | 0.180 |
Why?
|
| Biophysical Phenomena | 2 | 2010 | 112 | 0.180 |
Why?
|
| Protons | 3 | 2011 | 473 | 0.180 |
Why?
|
| Breast Neoplasms | 8 | 2014 | 15694 | 0.180 |
Why?
|
| Colonic Neoplasms | 1 | 2008 | 1390 | 0.180 |
Why?
|
| Sensitivity and Specificity | 7 | 2014 | 4971 | 0.180 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 1618 | 0.170 |
Why?
|
| Calibration | 2 | 2011 | 337 | 0.170 |
Why?
|
| Equipment Design | 4 | 2011 | 1204 | 0.160 |
Why?
|
| Software | 3 | 2013 | 1321 | 0.160 |
Why?
|
| Infrared Rays | 5 | 2012 | 54 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 1 | 2011 | 3976 | 0.140 |
Why?
|
| Mice, Nude | 6 | 2015 | 4307 | 0.130 |
Why?
|
| Dextrans | 1 | 2015 | 90 | 0.130 |
Why?
|
| Magnetite Nanoparticles | 1 | 2015 | 50 | 0.130 |
Why?
|
| Neovascularization, Pathologic | 2 | 2015 | 1547 | 0.130 |
Why?
|
| Neoplasms | 9 | 2015 | 15193 | 0.130 |
Why?
|
| Mice | 14 | 2015 | 34495 | 0.130 |
Why?
|
| Carcinoma | 1 | 2006 | 2578 | 0.120 |
Why?
|
| Liver | 4 | 2010 | 2961 | 0.120 |
Why?
|
| Thermal Conductivity | 1 | 2013 | 3 | 0.120 |
Why?
|
| Absorption | 1 | 2013 | 81 | 0.120 |
Why?
|
| Portal Pressure | 1 | 2013 | 13 | 0.120 |
Why?
|
| Ferric Compounds | 2 | 2011 | 73 | 0.120 |
Why?
|
| Optical Phenomena | 1 | 2013 | 26 | 0.120 |
Why?
|
| Spinal Cord Compression | 1 | 2015 | 151 | 0.120 |
Why?
|
| Biopsy, Needle | 3 | 2013 | 1363 | 0.120 |
Why?
|
| Fiducial Markers | 1 | 2014 | 96 | 0.120 |
Why?
|
| Catheter Ablation | 2 | 2010 | 620 | 0.110 |
Why?
|
| Cell Line, Tumor | 8 | 2015 | 14551 | 0.110 |
Why?
|
| Liver Neoplasms | 3 | 2019 | 4557 | 0.110 |
Why?
|
| Cobalt | 2 | 2010 | 55 | 0.110 |
Why?
|
| Acetylcysteine | 1 | 2014 | 143 | 0.110 |
Why?
|
| ErbB Receptors | 3 | 2011 | 2295 | 0.110 |
Why?
|
| Male | 24 | 2019 | 123000 | 0.110 |
Why?
|
| Radiation Injuries | 1 | 2020 | 1411 | 0.110 |
Why?
|
| Gadolinium DTPA | 4 | 2007 | 172 | 0.110 |
Why?
|
| Nanocapsules | 1 | 2012 | 28 | 0.100 |
Why?
|
| Lasers, Semiconductor | 1 | 2011 | 14 | 0.100 |
Why?
|
| Ultrasonography | 5 | 2010 | 1863 | 0.100 |
Why?
|
| Phototherapy | 2 | 2011 | 75 | 0.100 |
Why?
|
| Adipose Tissue | 3 | 2013 | 769 | 0.100 |
Why?
|
| Cryosurgery | 1 | 2013 | 167 | 0.100 |
Why?
|
| Gadolinium | 2 | 2010 | 164 | 0.100 |
Why?
|
| Time Factors | 8 | 2014 | 12926 | 0.100 |
Why?
|
| HSP27 Heat-Shock Proteins | 1 | 2011 | 33 | 0.100 |
Why?
|
| Capillary Permeability | 1 | 2011 | 114 | 0.100 |
Why?
|
| Nanostructures | 2 | 2009 | 94 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2011 | 220 | 0.090 |
Why?
|
| Nanotechnology | 2 | 2009 | 137 | 0.090 |
Why?
|
| Ultrasonography, Doppler | 1 | 2011 | 231 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2011 | 252 | 0.090 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2011 | 161 | 0.090 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 2403 | 0.090 |
Why?
|
| Energy Transfer | 1 | 2010 | 35 | 0.090 |
Why?
|
| Injections | 2 | 2007 | 285 | 0.090 |
Why?
|
| Spinal Neoplasms | 1 | 2015 | 631 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2013 | 726 | 0.090 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2011 | 204 | 0.090 |
Why?
|
| Organ Specificity | 1 | 2011 | 699 | 0.090 |
Why?
|
| Confidence Intervals | 1 | 2011 | 756 | 0.090 |
Why?
|
| Soft Tissue Neoplasms | 2 | 2010 | 882 | 0.090 |
Why?
|
| Diffusion | 1 | 2009 | 88 | 0.090 |
Why?
|
| Normal Distribution | 1 | 2009 | 61 | 0.090 |
Why?
|
| Electroplating | 1 | 2008 | 3 | 0.090 |
Why?
|
| Equipment Failure Analysis | 1 | 2010 | 329 | 0.080 |
Why?
|
| Gels | 1 | 2009 | 105 | 0.080 |
Why?
|
| Image-Guided Biopsy | 1 | 2011 | 327 | 0.080 |
Why?
|
| Iodine Radioisotopes | 1 | 2010 | 371 | 0.080 |
Why?
|
| Feedback | 1 | 2009 | 198 | 0.080 |
Why?
|
| Xenograft Model Antitumor Assays | 3 | 2011 | 3821 | 0.080 |
Why?
|
| Mammography | 1 | 2013 | 1010 | 0.080 |
Why?
|
| Intracranial Embolism | 1 | 2007 | 39 | 0.080 |
Why?
|
| Swine | 3 | 2013 | 1541 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2013 | 4744 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 2027 | 0.070 |
Why?
|
| Lipids | 1 | 2011 | 644 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2009 | 164 | 0.070 |
Why?
|
| Mice, Inbred BALB C | 2 | 2011 | 2314 | 0.070 |
Why?
|
| Brain Diseases | 1 | 2010 | 403 | 0.070 |
Why?
|
| Diagnostic Imaging | 2 | 2012 | 1162 | 0.070 |
Why?
|
| Female | 19 | 2019 | 141928 | 0.070 |
Why?
|
| General Surgery | 1 | 2010 | 326 | 0.070 |
Why?
|
| Neoplasm Transplantation | 3 | 2011 | 1519 | 0.070 |
Why?
|
| Liver Cirrhosis | 1 | 2013 | 941 | 0.070 |
Why?
|
| Treatment Outcome | 9 | 2019 | 32848 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 4 | 2011 | 7551 | 0.070 |
Why?
|
| Doxorubicin | 1 | 2013 | 3005 | 0.070 |
Why?
|
| Robotics | 1 | 2010 | 359 | 0.070 |
Why?
|
| Forecasting | 1 | 2009 | 694 | 0.070 |
Why?
|
| Regression Analysis | 1 | 2009 | 1546 | 0.070 |
Why?
|
| Positron-Emission Tomography | 2 | 2011 | 2173 | 0.070 |
Why?
|
| Retrospective Studies | 7 | 2020 | 37905 | 0.060 |
Why?
|
| Myocardium | 1 | 2011 | 1313 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 2 | 2007 | 624 | 0.060 |
Why?
|
| Paclitaxel | 1 | 2012 | 1996 | 0.060 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2007 | 341 | 0.060 |
Why?
|
| Elasticity | 3 | 1999 | 156 | 0.060 |
Why?
|
| Neoplasm Proteins | 1 | 2006 | 3230 | 0.060 |
Why?
|
| Monitoring, Physiologic | 2 | 2004 | 502 | 0.060 |
Why?
|
| Silicone Gels | 1 | 2004 | 28 | 0.060 |
Why?
|
| Abdomen | 1 | 2005 | 332 | 0.060 |
Why?
|
| Urethra | 1 | 2004 | 144 | 0.060 |
Why?
|
| Breast | 2 | 2013 | 1344 | 0.050 |
Why?
|
| Necrosis | 2 | 2020 | 580 | 0.050 |
Why?
|
| Computational Biology | 1 | 2009 | 1271 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 1374 | 0.050 |
Why?
|
| Antibodies, Monoclonal | 2 | 2011 | 4367 | 0.050 |
Why?
|
| Middle Aged | 11 | 2019 | 86204 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2000 | 132 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2011 | 4078 | 0.050 |
Why?
|
| ROC Curve | 2 | 2013 | 1183 | 0.050 |
Why?
|
| Glioma | 1 | 2011 | 1963 | 0.050 |
Why?
|
| Aged | 9 | 2019 | 70117 | 0.050 |
Why?
|
| Rabbits | 3 | 2012 | 957 | 0.040 |
Why?
|
| Environmental Monitoring | 1 | 2000 | 105 | 0.040 |
Why?
|
| Genetic Therapy | 1 | 2007 | 1616 | 0.040 |
Why?
|
| Kidney Neoplasms | 1 | 2013 | 3022 | 0.040 |
Why?
|
| Breast Implants | 1 | 2004 | 391 | 0.040 |
Why?
|
| Radiosurgery | 2 | 2020 | 1330 | 0.040 |
Why?
|
| Pilot Projects | 3 | 2011 | 2803 | 0.040 |
Why?
|
| Sheep | 1 | 1998 | 258 | 0.040 |
Why?
|
| Methylene Blue | 2 | 2007 | 54 | 0.040 |
Why?
|
| Biomarkers, Tumor | 1 | 2006 | 10331 | 0.040 |
Why?
|
| Transducers | 3 | 2004 | 59 | 0.040 |
Why?
|
| Magnetics | 2 | 2008 | 107 | 0.030 |
Why?
|
| Adenocarcinoma | 2 | 2011 | 7789 | 0.030 |
Why?
|
| Adult | 7 | 2018 | 77950 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2019 | 992 | 0.030 |
Why?
|
| Sus scrofa | 1 | 2013 | 169 | 0.030 |
Why?
|
| Nonlinear Dynamics | 1 | 2013 | 78 | 0.030 |
Why?
|
| Vacuum | 1 | 2012 | 42 | 0.030 |
Why?
|
| Photoacoustic Techniques | 1 | 2013 | 54 | 0.030 |
Why?
|
| Radiography | 2 | 2008 | 1904 | 0.030 |
Why?
|
| Colorectal Neoplasms | 1 | 2008 | 3578 | 0.030 |
Why?
|
| Reference Standards | 1 | 2013 | 339 | 0.030 |
Why?
|
| Injections, Intra-Arterial | 1 | 2012 | 62 | 0.030 |
Why?
|
| Random Allocation | 1 | 2013 | 703 | 0.030 |
Why?
|
| Optical Imaging | 1 | 2013 | 157 | 0.030 |
Why?
|
| Quality Control | 1 | 2013 | 457 | 0.030 |
Why?
|
| Combined Modality Therapy | 2 | 2015 | 8865 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2013 | 700 | 0.030 |
Why?
|
| Antineoplastic Agents | 2 | 2012 | 14289 | 0.030 |
Why?
|
| Observer Variation | 1 | 2013 | 671 | 0.030 |
Why?
|
| Absorbable Implants | 1 | 2012 | 65 | 0.030 |
Why?
|
| Lymphography | 1 | 2011 | 51 | 0.030 |
Why?
|
| Biopsy | 1 | 2019 | 3443 | 0.030 |
Why?
|
| Arabinofuranosyluracil | 1 | 2011 | 42 | 0.030 |
Why?
|
| Reference Values | 1 | 2013 | 1099 | 0.030 |
Why?
|
| Microspheres | 1 | 2012 | 210 | 0.030 |
Why?
|
| Molecular Imaging | 1 | 2013 | 185 | 0.030 |
Why?
|
| Lung Neoplasms | 3 | 2011 | 11538 | 0.020 |
Why?
|
| Indium | 1 | 2011 | 20 | 0.020 |
Why?
|
| Pain Measurement | 1 | 2015 | 953 | 0.020 |
Why?
|
| Uncertainty | 1 | 2013 | 320 | 0.020 |
Why?
|
| Thymidine Kinase | 1 | 2011 | 193 | 0.020 |
Why?
|
| Herpesvirus 1, Human | 1 | 2011 | 113 | 0.020 |
Why?
|
| Motion | 1 | 2011 | 193 | 0.020 |
Why?
|
| Lymphatic Vessels | 1 | 2011 | 143 | 0.020 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2011 | 173 | 0.020 |
Why?
|
| Prognosis | 2 | 2019 | 21713 | 0.020 |
Why?
|
| Anisotropy | 1 | 2010 | 181 | 0.020 |
Why?
|
| Artifacts | 1 | 2012 | 532 | 0.020 |
Why?
|
| Cetuximab | 1 | 2011 | 472 | 0.020 |
Why?
|
| Cell Separation | 1 | 2011 | 612 | 0.020 |
Why?
|
| Perfusion | 1 | 2010 | 293 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2013 | 2307 | 0.020 |
Why?
|
| Genes, Reporter | 1 | 2011 | 798 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 4320 | 0.020 |
Why?
|
| United States | 2 | 2021 | 15433 | 0.020 |
Why?
|
| Cattle | 1 | 2010 | 783 | 0.020 |
Why?
|
| Muscles | 1 | 2010 | 416 | 0.020 |
Why?
|
| Injections, Intravenous | 1 | 2010 | 573 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2019 | 2864 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2007 | 10035 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2013 | 2063 | 0.020 |
Why?
|
| Glass | 1 | 2008 | 30 | 0.020 |
Why?
|
| Respiration | 1 | 2011 | 447 | 0.020 |
Why?
|
| Nitrates | 1 | 2008 | 43 | 0.020 |
Why?
|
| Acrylates | 1 | 2008 | 30 | 0.020 |
Why?
|
| Solutions | 1 | 2008 | 104 | 0.020 |
Why?
|
| Biomarkers | 1 | 2019 | 5047 | 0.020 |
Why?
|
| Nanomedicine | 1 | 2008 | 54 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2013 | 29902 | 0.020 |
Why?
|
| Stereotaxic Techniques | 1 | 2008 | 172 | 0.020 |
Why?
|
| Ultrasonography, Doppler, Duplex | 1 | 2007 | 60 | 0.020 |
Why?
|
| Light | 1 | 2008 | 245 | 0.020 |
Why?
|
| Carotid Artery, Common | 1 | 2007 | 91 | 0.020 |
Why?
|
| Electric Impedance | 1 | 2007 | 100 | 0.020 |
Why?
|
| Monitoring, Intraoperative | 1 | 2008 | 264 | 0.020 |
Why?
|
| Subtraction Technique | 1 | 2007 | 141 | 0.020 |
Why?
|
| Immunotherapy | 1 | 2019 | 3341 | 0.020 |
Why?
|
| Echocardiography | 1 | 2011 | 1182 | 0.020 |
Why?
|
| Body Water | 1 | 2005 | 132 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2020 | 12873 | 0.020 |
Why?
|
| Endothelial Cells | 1 | 2011 | 1048 | 0.020 |
Why?
|
| Radiography, Interventional | 1 | 2007 | 305 | 0.020 |
Why?
|
| Cell Survival | 1 | 2011 | 3045 | 0.020 |
Why?
|
| Linear Models | 1 | 2007 | 1085 | 0.020 |
Why?
|
| Radiopharmaceuticals | 1 | 2010 | 1301 | 0.020 |
Why?
|
| Rats | 1 | 2013 | 6086 | 0.020 |
Why?
|
| Heating | 1 | 2004 | 8 | 0.020 |
Why?
|
| Silicon | 1 | 2003 | 48 | 0.010 |
Why?
|
| Young Adult | 2 | 2013 | 21445 | 0.010 |
Why?
|
| Sodium Chloride | 1 | 2004 | 156 | 0.010 |
Why?
|
| Cell Line | 1 | 2011 | 5114 | 0.010 |
Why?
|
| Radiation Dosage | 1 | 2008 | 1014 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2013 | 7548 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2010 | 4938 | 0.010 |
Why?
|
| Antineoplastic Protocols | 1 | 2002 | 33 | 0.010 |
Why?
|
| Catheterization | 1 | 2004 | 410 | 0.010 |
Why?
|
| Quality of Life | 1 | 2015 | 4532 | 0.010 |
Why?
|
| Lymph Nodes | 1 | 2011 | 2967 | 0.010 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 8873 | 0.010 |
Why?
|
| Survival Analysis | 1 | 2011 | 9180 | 0.010 |
Why?
|
| Antibodies, Monoclonal, Humanized | 1 | 2011 | 3251 | 0.010 |
Why?
|
| Mice, SCID | 1 | 2003 | 1869 | 0.010 |
Why?
|
| Incidence | 1 | 2009 | 5673 | 0.010 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2002 | 925 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2011 | 5542 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 14889 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1999 | 1270 | 0.010 |
Why?
|
| Adolescent | 1 | 2011 | 31252 | 0.010 |
Why?
|